Literature DB >> 27473379

Pathogen-induced secretory diarrhea and its prevention.

S Anand1, S Mandal2, P Patil1, S K Tomar1.   

Abstract

Secretory diarrhea is a historically known serious health implication around the world which primarily originates through pathogenic microorganisms rather than immunological or genetical disorders. This review highlights infective mechanisms of non-inflammatory secretory diarrhea causing pathogens, known therapeutics and their efficacy against them. These non-inflammatory diarrheal pathogens breach cell barriers, induce inflammation, disrupt fluid secretion across the epithelium by alteration in ion transport by faulting cystic fibrosis transmembrane conductance regulator (CFTR), calcium activated chloride channels and ion exchanger functions. Currently, a variety of prevention strategies have been used to treat these symptoms like use of antibacterial drugs, vaccines, fluid and nutritional therapy, probiotics and prebiotics as adjuncts. In progression of the need for a therapy having quick physiological effects, withdrawing the symptoms with a wide and safe therapeutic index, newer antisecretory agents like potent inhibitors, agonists and herbal remedies are some of the interventions which have come into light through greater understanding of the mechanisms and molecular targets involved in intestinal fluid secretion. Although these therapies have their own pros and cons inside the host, the quest for new antisecretory agents has been a successful elucidation to reduce burden of diarrheal disease.

Entities:  

Mesh:

Year:  2016        PMID: 27473379     DOI: 10.1007/s10096-016-2726-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  223 in total

Review 1.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

2.  Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli.

Authors:  Yuan-Kun Lee; Kim-Yoong Puong; Arthur C Ouwehand; Seppo Salminen
Journal:  J Med Microbiol       Date:  2003-10       Impact factor: 2.472

3.  The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity.

Authors:  Kim Hodges; Neal M Alto; K Ramaswamy; Pradeep K Dudeja; Gail Hecht
Journal:  Cell Microbiol       Date:  2008-04-21       Impact factor: 3.715

Review 4.  Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infections.

Authors:  Adrienne W Paton; Renato Morona; James C Paton
Journal:  Bioeng Bugs       Date:  2009-11-17

5.  Calcium-sensing receptor abrogates secretagogue- induced increases in intestinal net fluid secretion by enhancing cyclic nucleotide destruction.

Authors:  John Geibel; Kumudesh Sritharan; Rainer Geibel; Peter Geibel; J Scott Persing; Achim Seeger; Torsten K Roepke; Markus Deichstetter; Christian Prinz; Sam X Cheng; David Martin; Steven C Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-07       Impact factor: 11.205

6.  Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells.

Authors:  G Chauvière; M H Coconnier; S Kernéis; J Fourniat; A L Servin
Journal:  J Gen Microbiol       Date:  1992-08

7.  Probiotics affect virulence-related gene expression in Escherichia coli O157:H7.

Authors:  Maira Jessica Medellin-Peña; Haifeng Wang; Roger Johnson; Sanjeev Anand; Mansel W Griffiths
Journal:  Appl Environ Microbiol       Date:  2007-05-11       Impact factor: 4.792

8.  Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel.

Authors:  Ricardo De La Fuente; Wan Namkung; Aaron Mills; A S Verkman
Journal:  Mol Pharmacol       Date:  2007-12-14       Impact factor: 4.436

9.  In vitro inhibition of ETEC K88 adhesion by pea hulls and of LT enterotoxin binding by faba bean hulls.

Authors:  P M Becker; J van der Meulen; A J M Jansman; P G van Wikselaar
Journal:  J Anim Physiol Anim Nutr (Berl)       Date:  2011-09-19       Impact factor: 2.130

10.  Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

Authors:  Ronald H Behrens; Jakob P Cramer; Tomas Jelinek; Hilary Shaw; Frank von Sonnenburg; Darren Wilbraham; Thomas Weinke; David J Bell; Edwin Asturias; Hermann L Enkerlin Pauwells; Roberto Maxwell; Mercedes Paredes-Paredes; Gregory M Glenn; Shailesh Dewasthaly; Donald M Stablein; Zhi-Dong Jiang; Herbert L DuPont
Journal:  Lancet Infect Dis       Date:  2013-11-29       Impact factor: 25.071

View more
  2 in total

1.  Effect of Lactobacillus rhamnosus NCDC 298 with FOS in Combination on Viability and Toxin Production of Enterotoxigenic Escherichia coli.

Authors:  Santosh Anand; Surajit Mandal; Sudhir Kumar Tomar
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

2.  Serotonin involvement in okadaic acid-induced diarrhoea in vivo.

Authors:  M Carmen Louzao; Celia Costas; Paula Abal; Toshiyuki Suzuki; Ryuichi Watanabe; Natalia Vilariño; Cristina Carrera; Andrea Boente-Juncal; Carmen Vale; Mercedes R Vieytes; Luis M Botana
Journal:  Arch Toxicol       Date:  2021-06-20       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.